Sensus Healthcare Inc (SRTS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Sensus Healthcare Inc stock (SRTS) is currently trading at $3.96. Sensus Healthcare Inc PS ratio (Price-to-Sales) is 2.32. Analyst consensus price target for SRTS is $6.88. WallStSmart rates SRTS as Underperform.
- SRTS PE ratio analysis and historical PE chart
- SRTS PS ratio (Price-to-Sales) history and trend
- SRTS intrinsic value — DCF, Graham Number, EPV models
- SRTS stock price prediction 2025 2026 2027 2028 2029 2030
- SRTS fair value vs current price
- SRTS insider transactions and insider buying
- Is SRTS undervalued or overvalued?
- Sensus Healthcare Inc financial analysis — revenue, earnings, cash flow
- SRTS Piotroski F-Score and Altman Z-Score
- SRTS analyst price target and Smart Rating
Sensus Healthcare Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Sensus Healthcare Inc (SRTS) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, price/book, revenue growth. Concerns around market cap and return on equity. Fundamentals are solid but monitor weak areas for improvement.
Sensus Healthcare Inc (SRTS) Key Strengths (4)
Keeps $41 of every $100 in revenue after operating costs
Revenue surging 155.70% year-over-year
Earnings per share surging 433.30% year-over-year
Trading at 1.32x book value, attractively priced
Supporting Valuation Data
Sensus Healthcare Inc (SRTS) Areas to Watch (5)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Low institutional interest, mostly retail-driven
Revenue is fairly priced at 2.32x sales
Supporting Valuation Data
Sensus Healthcare Inc (SRTS) Detailed Analysis Report
Overall Assessment
This company scores 53/100 in our Smart Analysis, earning a C- grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.5/10) while 5 fall into concern territory (avg 2.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Operating Margin, Revenue Growth, EPS Growth. Valuation metrics including Price/Book (1.32) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 40.80%. Growth metrics are encouraging with Revenue Growth at 155.70%, EPS Growth at 433.30%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Market Cap. Some valuation metrics including Price/Sales (2.32) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -14.80%, Profit Margin at -28.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -14.80% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 155.70% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Operating Margin, Revenue Growth) and negatives (Return on Equity, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SRTS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SRTS's Price-to-Sales ratio of 2.32x trades 44% below its historical average of 4.16x (27th percentile). The current valuation is 78% below its historical high of 10.66x set in Nov 2021, and 186% above its historical low of 0.81x in Oct 2023. Over the past 12 months, the PS ratio has expanded from ~1.9x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Sensus Healthcare Inc (SRTS) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Sensus Healthcare Inc is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 27M with 156% growth year-over-year. The company is currently unprofitable, posting a -28.1% profit margin.
Key Findings
Revenue growing at 156% YoY, reaching 27M. This pace significantly outperforms most MEDICAL DEVICES peers.
The company is unprofitable with a -28.1% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Sensus Healthcare Inc maintain 156%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Sensus Healthcare Inc.
Bottom Line
Sensus Healthcare Inc is a high-conviction growth story with revenue accelerating at 156% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -28.1% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Sensus Healthcare Inc(SRTS)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide. The company is headquartered in Boca Raton, Florida.